Rechallenge of immune checkpoint inhibitors after immunerelated adverse events: A systematic review

被引：0
|
作者：
Kim, J. Y. [1 ]
Shin, C. [2 ]
Lee, S. [2 ]
Shin, S. [2 ]
机构：
[1] Keimyung Univ, Hematooncol Dept, Daegu, South Korea
[2] Keimyung Univ, Obstet & Gynecol, Dongsan Hosp, Daegu, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.957
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2176P
引用
收藏
页码：S1129 / S1129
页数：1
相关论文
共 50 条
  • [1] Neurologic Adverse Events of Immune Checkpoint Inhibitors A Systematic Review
    Marini, Alessandro
    Bernardini, Andrea
    Gigli, Gian Luigi
    Valente, Mariarosaria
    Muniz-Castrillo, Sergio
    Honnorat, Jerome
    Vogrig, Alberto
    NEUROLOGY, 2021, 96 (16) : 754 - 766
  • [2] Evaluation of immune checkpoint inhibitors rechallenge after immune-related adverse events in patients with cancer
    Tang, X-R.
    Li, R.
    Zhao, F.
    Wen, X.
    Wang, Y-K.
    Lv, R-X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1269 - S1269
  • [3] Clinical use of immune-checkpoint inhibitors: focus on late immunerelated adverse events and pseudoprogression
    Sini, C.
    Carta, A. M.
    Bardino, G.
    Saba, E. M.
    Coinu, A.
    Defraia, E.
    Ortu, S.
    Schintu, M. G.
    Pira, T.
    Frau, B.
    Soru, G.
    Masale, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis
    Gao, Wen
    Wu, Lingxiang
    Jin, Shidai
    Li, Jun
    Liu, Xinyin
    Xu, Jiali
    Zhang, Wei
    Gong, Qixing
    Sun, Chunxiao
    Wang, Wei
    Wang, Zidun
    Shao, Yang W.
    Yin, Jiani C.
    Shen, Lu
    Chen, Liang
    Wang, Qianghu
    Guo, Renhua
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)
  • [5] TARGETED THERAPIES FOR SEVERE IMMUNERELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS ARE NOT ASSOCIATED WITH A WORSE PROGNOSIS
    Sedmak, N.
    Sebbag, E.
    Loc, P. Tran Ba
    Fabacher, T.
    Bahougne, T.
    Arnold, C.
    Desjeux, G.
    Servy, H.
    Meyer, N.
    Sauleau, E.
    Seror, R.
    Gottenberg, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 178 - 178
  • [6] Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
    Gao, Ling
    Yang, Xi
    Yi, Cheng
    Zhu, Hong
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [7] A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
    Arnaud-Coffin, Patrick
    Maillet, Denis
    Gan, Hui K.
    Stelmes, Jean-Jacques
    You, Benoit
    Dalle, Stephane
    Peron, Julien
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (03) : 639 - 648
  • [8] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
    Zheng, Shu-Yue
    Duan, Hua
    Cui, Hui-Juan
    JAMA ONCOLOGY, 2020, 6 (11) : 1813 - 1813
  • [9] Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis
    Inno, Alessandro
    Roviello, Giandomenico
    Ghidini, Antonio
    Luciani, Andrea
    Catalano, Martina
    Gori, Stefania
    Petrelli, Fausto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [10] Lymphocyte Subpopulation Balances as a Blood Biomarker for ImmuneRelated Adverse Events in Patients Receiving Immune Checkpoint Inhibitors
    Fontsa, Mireille Diane Langouo
    Stabile, Mario
    Garavello, Andrea
    Delvaux, Pauline
    Goudsmit, Anouk
    Berghmans, Thierry
    Brandao, Mariana
    Blanc, Jeremy
    Lzkovitz, Maxime
    Meert, Anne-Pascale
    Boisson, Anais
    Sofronii, Doina
    Vanhulst, Thila
    Garaud, Soizic
    Abogunde, Francine Padonou
    Awada, Ahmad
    Willard-Gallo, Karen
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
12345